TYVALZI Injection is used in the management of Acute Cerebral Ischemic Stroke, a condition in which the loss of blood supply to the brain manages brain tissue from receiving oxygen and nutrients, resulting in potential brain damage. It contains a medicine called Sovateltide which stimulates the production of neural progenitor cells in the brain, supporting the generation of new brain cells and blood vessels post-cerebral ischemic stroke. This process enhances blood flow to the brain, promoting the survival of brain cells.
Studies have shown that, TYVALZI has anti-inflammatory, and antioxidant activity which helps in limiting brain cell damage and potentially restoring neurological and motor function in patients following a stroke.
TYVALZI Injection will be given to you only a trained doctor or by any competent healthcare professional into your veins (i.v.) as an intravenous bolus over one minute.
While undergoing therapy with TYVALZI Injection, it is important to take all doses exactly in the same dosing intervals as suggested by your doctor to see better results. Before taking this medicine, inform your doctor if you any bleeding in the brain or any other pre-existing disease conditions as a precaution.
There is no study information regarding the use of TYVALZI during pregnant, breastfeeding and in children (aged below 18 years). Therefore, inform your doctor before this medicine is administered to you.
TYVALZI Injection is generally well tolerated. If you experience any unpleasant side effects, consult your doctor.
No content available
